About AuriGen Medical
AuriGen Medical is a company based in Galway (Ireland) founded in 2016 by John Thompson and Tony O Halloran. AuriGen Medical has raised $2.9 million across 6 funding rounds from investors including EIT Health and European Union. AuriGen Medical offers products and services including Zenith LAAO Device. AuriGen Medical operates in a competitive market with competitors including AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
- Headquarter Galway, Ireland
- Founders John Thompson, Tony O Halloran
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aurigen Medical Uk Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.9 M (USD)
in 6 rounds
-
Latest Funding Round
$2.69 M (USD), Grant
Jun 01, 2023
-
Investors
EIT Health
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AuriGen Medical
AuriGen Medical offers a comprehensive portfolio of products and services, including Zenith LAAO Device.
Implantable device for occluding the left atrial appendage to prevent strokes.
People of AuriGen Medical
Unlock access to complete
Unlock access to complete
Funding Insights of AuriGen Medical
AuriGen Medical has successfully raised a total of $2.9M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $2.69 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $2.7M
-
First Round
First Round
(07 Jan 2018)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Grant - AuriGen Medical | Valuation |
investors |
|
| Jan, 2019 | Amount | Grant - AuriGen Medical | Valuation |
investors |
|
| Jul, 2018 | Amount | Grant - AuriGen Medical | Valuation |
investors |
Investors in AuriGen Medical
AuriGen Medical has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include EIT Health and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
Investments & Acquisitions by AuriGen Medical
Financial Statements - AuriGen Medical
Aurigen Medical Comparisons
Competitors of AuriGen Medical
AuriGen Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtaCor Medical, AtriCure, CardioFocus, Kestra Medical Technologies and EBR Systems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An implantable pacemaker system is developed for cardiac pacing therapy.
|
|
| domain | founded_year | HQ Location |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| domain | founded_year | HQ Location |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| domain | founded_year | HQ Location |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| domain | founded_year | HQ Location |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
Frequently Asked Questions about AuriGen Medical
AuriGen Medical was founded in 2016 and raised its 1st funding round 2 years after it was founded.
AuriGen Medical is headquartered in Galway, Ireland.
John Thompson is the current CEO of AuriGen Medical. They have also founded this company.
AuriGen Medical is a funded company, having raised a total of $2.9M across 6 funding rounds to date. The company's 1st funding round was a Grant of $2.86M, raised on Jan 07, 2018.
AuriGen Medical was established in 2016 in Galway, Ireland, within the medical devices sector. Trans-septal implants are developed to manage atrial fibrillation, addressing related conditions including stroke and arrhythmia. Operations are based in Ireland, with a focus on innovative implantation technologies for cardiac care. Leadership includes co-founders serving as CEO and CTO.
AuriGen Medical's top competitors include AtaCor Medical, AtriCure and CardioFocus.
AuriGen Medical offers Zenith LAAO Device.
AuriGen Medical has 2 investors. Key investors include EIT Health, and European Union.